Literature DB >> 11776379

T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma.

T Mori1, R Takada, R Watanabe, S Okamoto, Y Ikeda.   

Abstract

T-helper (Th)1/Th2 imbalance has been observed in a variety of pathological conditions, including malignant diseases. We evaluated the Th1/Th2 balance in peripheral blood Th cells by means of intracellular cytokine analysis in 19 patients with previously untreated B-cell diffuse large cell lymphoma (DLCL) and in 18 patients with B-cell DLCL who had achieved complete remission (CR) after chemotherapy. The mean percentage of Th2 in CD4 cells in patients with DLCL (5.00 +/- 2.20) and that of Th1 in CD4+ cells in patients in CR (32.42 +/- 11.30) were significantly increased in comparison with those in healthy volunteers, respectively (Th1; 23.02 +/- 9.45, Th2; 3.25 +/- 0.90; P<0.01). The mean ratio of Th1/Th2 was significantly lower in patients with DLCL (4.74 +/- 0.52) than in patients in CR (9.31 +/- 1.06; P<0.01) and in healthy volunteers (7.25 +/- 0.65; P<0.01). We conclude that the Th1/Th2 balance was polarized to Th2 in untreated DLCL patients and to Th1 in patients in CR, which suggests that a Th1/Th2 imbalance could play a role in lymphomagenesis and durable remission.

Entities:  

Mesh:

Year:  2001        PMID: 11776379     DOI: 10.1007/s00262-001-0232-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  15 in total

1.  Rapid proliferation of a different clone early after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

Authors:  Takehiko Mori; Junichi Tamaru; Michihide Tokuhira; Shigehisa Mori; Hiroshi Suzuki; Toru Abe; Tsutomu Takeuchi
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma.

Authors:  Xiaofeng Bi; Tongzhang Zheng; Qing Lan; Zhijian Xu; Yingtai Chen; Gongjian Zhu; Francine Foss; Christopher Kim; Min Dai; Ping Zhao; Theodore Holford; Brian Leaderer; Peter Boyle; Qian Deng; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Am J Hematol       Date:  2012-05-31       Impact factor: 10.047

3.  Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC.

Authors:  Roberto Martínez; Gustavo Tapia; Silvia De Muga; Alba Hernández; Maria González Cao; Cristina Teixidó; Victor Urrea; Elisabet García; Sònia Pedreño-López; Luis Ibarz; Julià Blanco; Bonaventura Clotet; Cecilia Cabrera
Journal:  Oncoimmunology       Date:  2019-04-13       Impact factor: 8.110

4.  Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Authors:  Qing Lan; Tongzhang Zheng; Nathaniel Rothman; Yawei Zhang; Sophia S Wang; Min Shen; Sonja I Berndt; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Meredith Yeager; Robert Welch; Peter Boyle; Bing Zhang; Kaiyong Zou; Yong Zhu; Stephen Chanock
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

5.  Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.

Authors:  Yingtai Chen; Tongzhang Zheng; Qing Lan; Francine Foss; Christopher Kim; Xuezhong Chen; Min Dai; Yumin Li; Theodore Holford; Brian Leaderer; Peter Boyle; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

6.  Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.

Authors:  Shannon M Conroy; Gertraud Maskarinec; Yukiko Morimoto; Adrian A Franke; Robert V Cooney; Lynne R Wilkens; Marc T Goodman; Brenda Y Hernadez; Loïc Le Marchand; Brian E Henderson; Laurence N Kolonel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-08       Impact factor: 4.254

Review 7.  Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.

Authors:  Tomás Alvaro; Luis de la Cruz-Merino; Fernando Henao-Carrasco; José Luis Villar Rodríguez; David Vicente Baz; Manuel Codes Manuel de Villena; Mariano Provencio
Journal:  J Biomed Biotechnol       Date:  2010-08-12

8.  Polymorphisms in Th1/Th2 cytokine genes, hormone replacement therapy, and risk of non-Hodgkin lymphoma.

Authors:  Gongjian Zhu; Dongsheng Pan; Tongzhang Zheng; Qing Lan; Xuezhong Chen; Yingtai Chen; Christopher Kim; Xiaofeng Bi; Theodore Holford; Peter Boyle; Brian Leaderer; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Front Oncol       Date:  2011-07-28       Impact factor: 6.244

9.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

Review 10.  Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Sarah M Tete; Marc Bijl; Surinder S Sahota; Nicolaas A Bos
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.